Reproductive factors and NOS3 variant interactions in primary open-angle glaucoma

Molecular Vision

Volumn 17, Issue , 2011, Pages 2544-2551

  Kang, Jae Hee ^a   Wiggs, Janey L ^b   Haines, Jonathan ^c   Abdrabou, Wael ^b   Pasquale, Louis R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GLUTAMIC ACID; ORAL CONTRACEPTIVE AGENT;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DNA MODIFICATION; DNA POLYMORPHISM; DRUG USE; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; NITRIC OXIDE SYNTHASE 3 GENE; OPEN ANGLE GLAUCOMA; PARITY; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK FACTOR; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MENARCHE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; PARITY; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 83055170871     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Pollock JS, Forstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 1991; 88:10480-4. [PMID: 1720542]
2. Nathanson JA, McKee M. Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 1995; 36:1765-73. [PMID: 7543462]
3. Garthwaite G, Bartus K, Malcolm D, Goodwin D, Kollb-Sielecka M, Dooldeniya C, Garthwaite J. Signaling from blood vessels to CNS axons through nitric oxide. J Neurosci 2006; 26:7730-40. [PMID: 16855101]
4. Feke GT, Pasquale LR. Retinal blood flow response to posture change in glaucoma patients compared with healthy subjects. Ophthalmology 2008; 115:246-52. [PMID: 17689612]
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-6. [PMID: 6253831]
6. Ignarro LJ, Buga GM, Byrns RE, Wood KS, Chaudhuri G. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle. J Pharmacol Exp Ther 1988; 246:218-26. [PMID: 2839663]
7. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-9. [PMID: 2827174]
8. Dismuke WM, Ellis DZ. Activation of the BK(Ca) channel increases outflow facility and decreases trabecular meshwork cell volume. J Ocul Pharmacol Ther 2009; 25:309-14. [PMID: 19552602]
9. Dismuke WM, Mbadugha CC, Ellis DZ. NO-induced regulation of human trabecular meshwork cell volume and aqueous humor outflow facility involve the BKCa ion channel. Am J Physiol Cell Physiol 2008; 294:C1378-86. [PMID: 18385281]
10. Ellis DZ, Dismuke WM, Chokshi BM. Characterization of soluble guanylate cyclase in NO-induced increases in aqueous humor outflow facility and in the trabecular meshwork. Invest Ophthalmol Vis Sci 2009; 50:1808-13. [PMID: 19074804]
11. Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology 2002; 109:1047-51. [PMID: 12045042]
12. Affinito P, Di Spiezio Sardo A, Di Carlo C, Sammartino A, Tommaselli GA, Bifulco G, Loffredo M, Nappi C. Effects of hormone replacement therapy on ocular function in postmenopause. Menopause 2003; 10:482-7. [PMID: 14501611]
13. Sorrentino C, Affinito P, Mattace Raso F, Loffredo M, Merlino P, Loffredo A, Merlino P, Loffredo A, Palomba S, Nappi C. Effect of hormone replacement therapy on postmenopausal ocular function. Minerva Ginecol 1998; 50:19-24. [PMID: 9577151]
14. Sator MO, Joura EA, Frigo P, Kurz C, Metka M, Hommer A, Huber JC. Hormone replacement therapy and intraocular pressure. Maturitas 1997; 28:55-8. [PMID: 9391995]
15. Uncu G, Avci R, Uncu Y, Kaymaz C, Develioglu O. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006; 22:501-5. [PMID: 17071534]
16. Altintaş O, Caglar Y, Yuksel N, Demirci A, Karabas L. The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and ocular blood flow. Ophthalmologica 2004; 218:120-9. [PMID: 15004502]
17. Harris-Yitzhak M, Harris A, Ben-Refael Z, Zarfati D, Garzozi HJ, Martin BJ. Estrogen-replacement therapy: effects on retrobulbar hemodynamics. Am J Ophthalmol 2000; 129:623-8. [PMID: 10844054]
18. Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004; 11:69-77. [PMID: 14716185]
19. Hulsman CA, Westendorp IC, Ramrattan RS, Wolfs RC, Witteman JC, Vingerling JR, Hofman A, de Jong PT. Is openangle glaucoma associated with early menopause? The Rotterdam Study. Am J Epidemiol 2001; 154:138-44. [PMID: 11447046]
20. Yang S, Bae L, Zhang L. Estrogen increases eNOS and NOx release in human coronary artery endothelium. J Cardiovasc Pharmacol 2000; 36:242-7. [PMID: 10942167]
21. Ohmichi M, Kanda Y, Hisamoto K, Morishige K, Takahashi K, Sawada K, Minekawa R, Tasaka K, Murata Y. Rapid changes of flow-mediated dilatation after surgical menopause. Maturitas 2003; 44:125-31. [PMID: 12590008]
22. Khorram O, Garthwaite M, Magness RR. Endometrial and myometrial expression of nitric oxide synthase isoforms in pre-and postmenopausal women. J Clin Endocrinol Metab 1999; 84:2226-32. [PMID: 10372735]
23. Perera M, Petrie JR, Hillier C, Small M, Sattar N, Connell JM, Lumsden MA. Hormone replacement therapy can augment vascular relaxation in post-menopausal women with type 2 diabetes. Hum Reprod 2002; 17:497-502. [PMID: 11821303]
24. Pasquale LR, Rosner BA, Hankinson SE, Kang JH. Attributes of female reproductive aging and their relation to primary open-angle glaucoma: a prospective study. J Glaucoma 2007; 16:598-605. [PMID: 18091177]
25. Kang JH, Wiggs JL, Rosner BA, Hankinson SE, Abdrabou W, Fan BJ, Haines J, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with sex and postmenopausal hormone use. Invest Ophthalmol Vis Sci 2010; 51:971-9. [PMID: 19815736]
26. Barton J, Bain C, Hennekens CH, Rosner B, Belanger C, Roth A, Speizer FE. Characteristics of respondents and nonrespondents to a mailed questionnaire. Am J Public Health 1980; 70:823-5. [PMID: 7416342]
27. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992; 135:1114-26. [PMID: 1632423]
28. Kang JH, Willett WC, Rosner BA, Hankinson SE, Pasquale LR. Prospective study of alcohol consumption and risk of primary open-angle glaucoma. Ophthalmic Epidemiol 2007
29. Barrett JC, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21:263-5. [PMID: 15297300]
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc, B 1995; 57:289-300.
31. Pasquale LR, Kang JH. Female reproductive factors and primary open-angle glaucoma in the Nurses' Health Study. Eye (Lond) 2011; 25:633-41. [PMID: 21336255]
32. Lee AJ, Mitchell P, Rochtchina E, Healey PR. Female reproductive factors and open angle glaucoma: the Blue Mountains Eye Study. Br J Ophthalmol 2003; 87:1324-8. [PMID: 14609824]
33. Tempfer C, Moreno RM, O'Brien WE, Gregg AR. Genetic contributions of the endothelial nitric oxide synthase gene to ovulation and menopause in a mouse model. Fertil Steril 2000; 73:1025-31. [PMID: 10785232]
34. Miyamoto Y, Saito Y, Nakayama M, Shimasaki Y, Yoshimura T, Yoshimura M, Harada M, Kajiyama N, Kishimoto I, Kuwahara K, Hino J, Ogawa E, Hamanaka I, Kamitani S, Takahasi N, Kawakami R, Kangawa K, Yasue H, Nakao K. Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a-786T→C mutation associated with coronary spastic angina. Hum Mol Genet 2000; 9:2629-37. [PMID: 11063722]
35. Tanus-Santos JE, Desai M, Deak LR, Pezullo JC, Abernethy DR, Flockhart DA, Freedman JE. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 2002; 12:407-13. [PMID: 12142730]
36. Tawfik HE, Cena J, Schulz R, Kaufman S. Role of oxidative stress in multiparity-induced endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 295:H1736-42. [PMID: 18757488]
37. Kang JH, Wiggs JL, Rosner BA, Haines J, Abdrabou W, Pasquale LR. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma interactions with hypertension, alcohol Intake, and cigarette smoking. Arch Ophthalmol 2011; 129:773-80. [PMID: 21670344]
38. Buys ES, Hayton S, Jones A, Ko Y-C, Gregory M, Gong H, Brouckaert P, Pasquale LR, Bloch KD, Ksander B. sGC alpha 1 deficient mice: a novel model of spontaneous primary openangle glaucoma. ARVO Annual Meeting; 2011 May 1-5; Fort Lauderdale (FL).
39. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, DeWan A, Sigurdsson A, Jonasdottir A, Gudjonsson SA, Magnusson KP, Stefansson H, Lam DS, Tam PO, Gudmundsdottir GJ, Southgate L, Burdon KP, Gottfredsdottir MS, Aldred MA, Mitchell P, St Clair D, Collier DA, Tang N, Sveinsson O, Macgregor S, Martin NG, Cree AJ, Gibson J, Macleod A, Jacob A, Ennis S, Young TL, Chan JC, Karwatowski WS, Hammond CJ, Thordarson K, Zhang M, Wadelius C, Lotery AJ, Trembath RC, Pang CP, Hoh J, Craig JE, Kong A, Mackey DA, Jonasson F, Thorsteinsdottir U, Stefansson K. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet 2010; 42:906-9. [PMID: 20835238]
40. Rosa RH Jr, Hein TW, Yuan Z, Xu W, Pechal MI, Geraets RL, Newman JM, Kuo L. Brimonidine evokes heterogeneous vasomotor response of retinal arterioles: diminished nitric oxide-mediated vasodilation when size goes small. Am J Physiol Heart Circ Physiol 2006; 291:H231-8. [PMID: 16489103]
41. Kent AR, King L, Bartholomew LR. Vitreous concentration of topically applied brimonidine-purite 0.15%. J Ocul Pharmacol Ther 2006; 22:242-6. [PMID: 16910864]
42. Kent AR, Nussdorf JD, David R, Tyson F, Small D, Fellows D. Vitreous concentration of topically applied brimonidine tartrate 0.2%. Ophthalmology 2001; 108:784-7. [PMID: 11297498]
43. Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol 2011; 151:671-81. [PMID: 21257146]
44. Leung DY, Li FC, Kwong YY, Tham CC, Chi SC, Lam DS. Simvastatin and disease stabilization in normal tension glaucoma: a cohort study. Ophthalmology 2010; 117:471-6. [PMID: 20045568]
45. De Castro DK, Punjabi OS, Bostrom AG, Stamper RL, Lietman TM, Ray K, Lin SC. Effect of statin drugs and aspirin on progression in open-angle glaucoma suspects using confocal scanning laser ophthalmoscopy. Clin Experiment Ophthalmol 2007; 35:506-13. [PMID: 17760631]
46. Tielsch JM, Katz J, Singh K. A population-based evaluation of glaucoma screening; the Baltimore Eye Survey. Am J Epidemiol 1991; 134:1102-10. [PMID: 1746520]